<DOC>
	<DOCNO>NCT02519075</DOCNO>
	<brief_summary>Prospective exploratory study specifically investigate diagnostic predictive role 11C-Choline PET/CT DWI MRI response assessment patient affect HCC candidate TARE . A minimum number 20 patient consider analysis .</brief_summary>
	<brief_title>11C-Choline PET/CT DWI MRI Response Assessment HCC Candidate TARE</brief_title>
	<detailed_description>For study , patient histological diagnosis HCC eligible TARE , i.e . liver predominant disease eligible curative surgery , multidisciplinary discussion include . In case , patient undergo 11C-Choline PET/CT DWI MRI start radioembolization subsequently restaged 3 month treatment completion . A minimum number 20 patient consider analysis .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>patient histological diagnosis HCC eligible TARE , i.e . liver predominant disease eligible curative surgery , multidisciplinary discussion include ; obtain informed consent patient age &lt; 18 year pregnancy breastfeeding ; patient affect malignancy within last 3 year ; disseminate extrahepatic disease ; severely abnormal excretory liver function test ascites suggestive liver failure ; hepatopulmonary shunt &gt; 20 % ; vascular variant abnormality demonstrate pretreatment angiography , correct embolisation lead reflux hepatic arterial blood stomach , pancreas bowel .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hepatocarcinoma</keyword>
	<keyword>TARE</keyword>
	<keyword>response assessment</keyword>
</DOC>